A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
BeOne Medicines
NiKang Therapeutics, Inc.
AstraZeneca
Eli Lilly and Company
Kivu Bioscience Inc.
Pfizer
Exscientia AI Limited
Conjupro Biotherapeutics, Inc.
Sotio Biotech Inc.
National Institutes of Health Clinical Center (CC)
Radiopharm Theranostics, Ltd
National Cancer Institute (NCI)
PMV Pharmaceuticals, Inc
NeoImmuneTech
Neonc Technologies, Inc.
Radiopharm Theranostics, Ltd
MacroGenics
SystImmune Inc.
SN BioScience
ImmunityBio, Inc.
GV20 Therapeutics
DualityBio Inc.
Incyte Corporation
M.D. Anderson Cancer Center
NiKang Therapeutics, Inc.
Merck Sharp & Dohme LLC
Pfizer
Incyte Corporation
University of Virginia
Incyte Corporation
Telix Pharmaceuticals (Innovations) Pty Limited
Marengo Therapeutics, Inc.
OncoC4, Inc.
Klus Pharma Inc.
Theratechnologies
National Institutes of Health Clinical Center (CC)
Inspirna, Inc.
SOLTI Breast Cancer Research Group
Stanford University
Heronova Pharmaceuticals
Cybrexa Therapeutics
Cyteir Therapeutics, Inc.
BeiGene
Carisma Therapeutics Inc
Tasly Biopharmaceuticals Co., Ltd.
Sellas Life Sciences Group
23andMe, Inc.
Vincerx Pharma, Inc.
AstraZeneca
Mundipharma Research Limited